Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Veinplicity for Improved Venous Access: The VIVA Trial

NCT03752632 is registered in ClinicalTrials.gov with Physeon GmbH as lead sponsor.

NCT NCT03752632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Veinplicity for Improved Venous Access: The VIVA Trial
Lead sponsor
Physeon GmbH
Phase
Phase 3
Overall status
Terminated
Start date
November 1, 2018
Completion date
July 22, 2019
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

difficult-to-access veins for intravenous cannulation